Clinical Trials
3 trialsNCT04841811 2026-05-22
APPROACH
Guangdong Association of Clinical Trials
Phase 3 Active not recruiting
NCT06300424 2026-04-29
NEOVADE
Guangdong Provincial People's Hospital
Phase 2 Active not recruiting
NCT04685070 2024-08-14
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Active not recruiting